Table 2.
Percentages of US Adults, Overall and in Selected Subgroups, Meeting the Definition for Hypertension According to the ACC/AHA Guideline, 2014 Expert Panel Report, and JNC7 Based on the 2013 to 2016 PINNACLE Registry Data
| Subgroups | ACC/AHA guideline | 2014 Report | Difference between ACC/AHA guideline and 2014 report | JNC7 | Difference between ACC/AHA guideline and JNC7 |
|---|---|---|---|---|---|
| Overall (N=6 042 630) | 83.21 (83.18–83.24) | 74.82 (74.79–74.86) | 8.39 (8.36–8.41) | 75.23 (75.20–75.27) | 7.98 (7.95–8.00) |
| Age group, y | |||||
| 18–44 (N=892 971) | 53.66 (53.55–53.76) | 36.06 (35.96–36.16) | 17.60 (17.52–17.68) | 36.06 (35.96–36.16) | 17.60 (17.52–17.68) |
| 45–54 (N=806 202) | 78.41 (78.32–78.50) | 66.01 (65.91–66.11) | 12.40 (12.33–12.47) | 66.01 (65.91–66.11) | 12.40 (12.33–12.47) |
| 55–64 (N=1 280 248) | 86.13 (86.07–86.19) | 77.77% (77.70–77.84) | 8.36 (8.32–8.41) | 78.16 (78.09–78.23) | 7.97 (7.93–8.02) |
| 65–74 (N=1 569 242) | 90.73 (90.69–90.78) | 85.13 (85.07–85.19) | 5.60 (5.57–5.64) | 85.84 (85.78–85.89) | 4.90 (4.86–4.93) |
| ≥75 (N=1 493 967) | 93.05 (93.01–93.09) | 89.40 (89.35–89.45) | 3.66 (3.63–3.69) | 89.97 (89.93–90.02) | 3.08 (3.05–3.11) |
| Men (N=2 888 411) | 87.49 (87.45–87.52) | 79.38 (79.33–79.43) | 8.11 (8.07–8.14) | 79.76 (79.71–79.80) | 7.73 (7.70–7.76) |
| Women (N=3 148 983) | 79.27 (79.23–79.32) | 70.62 (70.57–70.67) | 8.65 (8.62–8.68) | 71.06 (71.01–71.11) | 8.21 (8.18–8.24) |
| Race or ethnicity | |||||
| White (N=3 933 307) | 82.74 (82.70–82.77) | 74.04 (73.99–74.08) | 8.70 (8.67–8.73) | 74.49 (74.45–74.54) | 8.24 (8.21–8.27) |
| Black (N=432 202) | 87.45 (87.35–87.54) | 79.79 (79.67–79.91) | 7.66 (7.58–7.74) | 80.08 (79.96–80.20) | 7.36 (7.29–7.44) |
| Other (N=28 139) * | 81.31 (80.85–81.77) | 73.12 (72.60–73.64) | 8.19 (7.87–8.52) | 73.44 (72.92–73.96) | 7.87 (7.56–8.19) |
| Hispanic (N=255 374) | 79.91 (79.76–80.07) | 71.50 (71.32–71.67) | 8.42 (8.31–8.53) | 71.78 (71.60–71.95) | 8.14 (8.03–8.24) |
| Non‐Hispanic (N=5 787 256) | 83.35 (83.32–83.38) | 74.97 (74.93–75.01) | 8.38 (8.36–8.41) | 75.38 (75.35–75.42) | 7.97 (7.95–7.99) |
| 10‐y ASCVD risk categories, % | |||||
| <5 (N=30 796) | 70.16 (69.65–70.67) | 55.21 (54.65–55.76) | 14.95 (14.56–15.36) | 55.28 (54.73–55.84) | 14.88 (14.48–15.28) |
| 5–<10 (N=21 241) | 85.39 (84.90–85.86) | 74.49 (73.90–75.08) | 10.89 (10.48–11.32) | 74.93 (74.34–75.51) | 10.46 (10.05–10.88) |
| 10–<20 (N=24 609) | 91.02 (90.65–91.37) | 83.60 (83.13–84.06) | 7.42 (7.09–7.75) | 84.06 (83.60–84.51) | 6.96 (6.64–7.28) |
| ≥20% (N=21 394) | 96.40 (96.14–96.64) | 92.68 (92.33–93.03) | 3.71 (3.46–3.97) | 93.11 (92.77–93.45) | 3.28 (3.05–3.53) |
| History of CVD (N=2 585 483) | 92.82 (92.79–92.85) | 89.49 (89.45–89.52) | 3.33 (3.31–3.35) | 89.68 (89.64–89.72) | 3.14 (3.12–3.16) |
Proportions and 95% Clopper‐Pearson (exact) CIs were reported. In each row, we presented the percentage of patients with hypertension and patients with guideline‐recommended antihypertensive medication in each subgroup. ACC indicates American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic CVD; CVD, cardiovascular disease; JNC7, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; and PINNACLE, Practice Innovation and Clinical Excellence.
*Defined as combination of any race other than White or Black, including Asian, American Indian/Alaskan Native, Native Hawaiin/Pacific Islander.